Company Name: EndoQuest Robotics
Location: Houston, TX
Sector: Medical Device/Robotics
Funding Details: Raised $42M in C-1 funding, led by CE Ventures and McNair Interests, with Puma Venture Capital LLC as a new investor.
Purpose of Investment: To further R&D, achieve regulatory milestones, commercialize their technology, and solidify their leadership in flexible endoluminal robotics.
Leadership: CEO Kurt Azarbarzin
Product: An innovative robotic system for gastrointestinal (GI) and other endoluminal surgeries, designed to offer precision, flexibility, and improved patient outcomes with minimally invasive interventions.
About Company: EndoQuest Robotics is pioneering the development of endoluminal robotic technologies aimed at transforming GI and other luminal surgeries. Their focus on creating a flexible robotic system underscores their commitment to advancing minimally invasive surgical techniques and enhancing patient care.
Innovation and Impact:
- Flexible Robotic System: Targets the unmet needs in GI surgeries with a robotic system that emphasizes precision and minimally invasive procedures.
- Advancing Minimally Invasive Surgeries: Aims to improve patient outcomes by reducing recovery time and surgical complications.
- Enhancing Healthcare Professional Capabilities: Provides healthcare professionals with advanced tools for performing complex endoluminal procedures.